Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1983;61:109-112
© 1983 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fraser, I S
Right arrow Articles by Smyth, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fraser, I S
Right arrow Articles by Smyth, E.

LONG-TERM TREATMENT OF MENORRHAGIA WITH MEFENAMIC ACID

I S Fraser, MB, ChB, G. McCarron, R. Markham, M. Robinson and E. Smyth

From the Department of Obstetrics and Gynaecology, University of Sydney, New South Wales, Australia

Thirty-six women with menorrhagia were treated with mefenamic acid during all menstrual periods for more than 1 year. These women had experienced objective and subjective benefit—menstrual blood loss was reduced and other menstrual symptoms improved during a preliminary 4-cycle double-blind placebo-controlled trial with mefenamic acid (placebo cycles: 65.6 ± 5.3 ml; mefenamic acid cycles: 45.3 ± 5.1 ml, mean ± SEM); This reduction in menstrual blood loss was maintained at 6 to 9 months (49.2 ± 9.9 ml) and at 12 to 15 months (42.8 ± 4.8 ml) after the trial, these reductions were significant at the 6- to 9-month (paired t test=2.18; P<.05) and the 12- to 15-month interval (paired t test=4.40; P<.001). Significant sustained reductions in blood loss were seen in the women with menorrhagia due to ovulatory dysfunctional bleeding and in those who had undergone tubal sterilization. Significant reductions were also seen in dysmenorrhea, headache, nausea, diarrhea, depression, number of sanitary towels used, and number of mefenamic acid capsules taken. A significant increase in serum ferritin was found between admission and completion of the follow-up trial in 11 women (P<.01).




This article has been cited by other articles:


Home page
West J Nurs ResHome page
J. F. Shaver, N. F. Woods, V. Wolf-Wilets, M. M. Heitkemper, K. C. Buckwalter, and M. Boyd
Menstrual Experiences: Comparisons of Dysmenorrheic and Nondysmenorrheic Women
West J Nurs Res, November 1, 1987; 9(4): 423 - 444.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American College of Obstetricians and Gynecologists.